Post Scrip: The ASPL Pharmacy Law Podcast

In this episode of Post-Script, Henry introduces Spreeha Choudhury, PharmD, JD and Kevin Nicholson, RPh, JD , who bring deep expertise in pharmacy law and policy to help navigate the evolving post-election landscape for pharmacy practice. Spreeha and Kevin give us a preview of their upcoming conference session, Navigating Pharmacy Law Under the Trump Administration: Implications for Pharmacist Sco...

In this episode of Post-Script, Henry introduces Bradley Wasser, Esquire , who brings deep expertise at the intersection of law, technology, and healthcare to help attorneys and pharmacy professionals navigate the rise of artificial intelligence in legal practice. Bradley gives us a preview of his upcoming conference session, Professional Responsibility in a Rapidly Evolving Legal and Technologica...

In this episode of Post-Script, Henry introduces Jeff Mesaros, PharmD, JD and Jean-Pierre Emond, PhD , who bring deep expertise in pharmacy law and cold chain logistics to help navigate the evolving landscape of mail order pharmacy regulations. Jeff and Jean-Pierre give us a preview of their upcoming conference session, Regulatory and Legal Developments in Mail Order Pharmacy, where they'll e...

In this episode of Post-Script, Henry introduces  Heidi McKinnon, PharmD, CHC , founder of RxExpert Insights , former Board of Pharmacy investigator, and former Head of Compliance and SIU oversight at a national PBM. With more than 20 years of experience inspecting pharmacies, responding to audits, and leading fraud, waste, and abuse (FWA) programs, Heidi brings unmatched insight into how audits w...

In this episode of Post-Script, Henry introduces Mark Boesen, PharmD, JD, founding partner of Boesen and Snow law firm. They discuss Mark's upcoming presentation "Pharmacists Aren't Telemedicine Police, But You Will Be Treated Like You Are." This presentation will address the growing regulatory scrutiny facing pharmacies dispensing telemedicine prescriptions, as state regulator...

In this special edition premiere of Post Scrip , host Henry sits down with Dr. Jerry Avorn, MD, Harvard Medical School professor and author of the groundbreaking book Rethinking Medications: Truth, Power and the Drugs You Take. Dr. Avorn, a senior internist at Mass General Brigham and author of over 600 papers, takes us on a dive into the complex world of drug approval, pricing, and pharmaceutical...

In this episode of Post-Scrip, Henry introduces Jenni Wai, RPh. , MBA, Josh Bolin and Christopher R. Smith, JD, LLM. They discuss the upcoming "Regulatory, Industry and Legal Perspectives on the Future of the DSCSA". This presentation will provide an update on the final stages of implementation of the DSCSA and anticipated future regulatory efforts. We will begin with a brief high level...

In this episode of Post-Scrip, Henry introduces Marty Allain, JD. They discuss the upcoming "How Drug Manufacturer Restrictions and Recent Court Decisions are Re-Shaping 340B Drug Distribution and Delivery Models". Pharmaceutical manufacturers continue to restrict the delivery of 340B drug discounts to contract pharmacies in response to the growth of 340B sales, perceived non-compliance...

In this episode of Post-Scrip, Henry introduces Amanda Ward, PharmD, MS, BCGP. They discuss the upcoming "DASPL Class II Capsule Projects".  As pharmacists continue to move beyond traditional roles in a dispensing pharmacy, state boards of pharmacy may have additional types of licensure pharmacists must have to perform those services. A review of all 50 states boards of pharmacy will rev...

In this episode of Post-Scrip, Henry introduces Roger N. Morris, JD, RPh. They discuss the upcoming "Case Law Update".  ASPL’s annual case law update will provide summaries of court decisions, lawsuits, and settlements from the last twelve months. The presentation will explore a variety of civil and criminal cases at the state and federal level involving pharmacy employment issues, fraud...

In this episode of Post-Scrip, Henry introduces Jeff Mesaros, PharmaD, MS, JD. They discuss the upcoming "Pharmacy Law Educators' Session - Using AI in the classroom".  This session begins with a presentation of using AI in the classroom followed by a panel session addressing implementation and regulation of AI in pharmacy practice. Join us at the 35th annual conference:  Developmen...

In this episode of Post-Scrip, Henry introduces Jeffrey S. Baird, JD. They discuss the upcoming "Advising a Pharmacy on Compliance Issues: Ethics Concerns".  Health care attorneys are in a unique place. When they advise health care providers (e.g., pharmacies), there are civil implications, potential criminal implications, and there are ethical challenges.  This program will discuss (i)...

In this episode of Post-Scrip, Henry introduces Kelli A. Boyden, JD; MS Pharmaceutical Sciences (Regulation) (2024). They discuss the upcoming "Key Supreme Court Decisions Impacting Pharmacies".  This presentation will focus on The U.S. Supreme Court’s rulings this year carry real-world effects on the pharmacy industry, including the FDA’s approval of mifepristone and addressing the stan...

In this episode of Post-Scrip, Henry introduces Douglas Braun, PharmaD, RPh, CPh, CSP. They discuss the upcoming "Impact of Inflation Reduction Act on Prescription drug costs, access and the financial impact of Medicare D reimbursement." The implementation of the Inflation Reduction Act in 2024 has a significant impact on both pharmacies and patients. Patients covered under Medicare Part...

In this episode of Post-Scrip, Henry introduces Steven Postal, JD. They discuss the ASPL publications editing. Steve Postal is the Publications Editor at ASPL and the Director of Policy and Regulatory Affairs at NCPA. His areas of expertise include Medicare Part D, compounding, and Medicaid. Before joining NCPA in April 2022, he worked for the American Physical Therapy Association in federal regul...

In this episode of Post-Scrip, Henry introduces Anthony P. Morreale, PharmD, MBA, BPCS, CPEL, FASHP. They discuss the upcoming "Pharmacogenomic Explosion: Legal and Liability Implications".   This presentation will focus on the rapid advancement of the science and its impact on prescribing and managing drug therapy and the consequences of ignoring pharmacogenomic evidence that is now pre...

In this episode of Post-Scrip, Henry introduces Jeanne M. Brennan, BS Pharm, JD, and, William J. Stilling, BS Pharm, MS, JD.  They discuss the upcoming Semaglutide as a Case Study for Compounding Legal Issues and Barriers Semaglutide provides a case study for pharmacists who are trying to meet patient and prescriber needs and who strive to comply with federal and state laws and the explosive deman...

In this episode of Post-Scrip, Henry introduces Mary Canavan, JD and Kyle A. Vasquez, JD, LLM. They discuss the upcoming 340B Program Preservation and Compliance. In this session, participants will learn how use the 340B statute and guidance to preserve 340B savings. In a climate where manufacturers and payors are uniformly taking action that harms covered entities (and patients), covered entities...

In this episode of Post-Scrip, Henry introduces Christopher R. Smith, JD, LLM. Henry and Chris discuss the upcoming. Drug Supply Chain Security Act Changes and Implications for Dispensers.  The presentation will provide an overview of the enhanced drug distribution requirements under the DSCSA and DSCSA interoperable electronic exchange requirements starting in November 2023. Specifically, the pre...

In this episode of Post-Scrip, Henry introduces  Todd A. Nova, J.D. Henry and Todd discuss the upcoming Current Trends in Retail & Specialty Pharmacy Pricing Compliance: Balancing Opportunity and Risk. The role that retail and specialty pharmacies play in the healthcare delivery system continues to increase in importance as the drug product pipeline continues its inexorable shift to more self-...

In this episode of Post-Scrip, Henry introduces  Marty Allain, JD. Henry and Marty discuss the upcoming Emerging Pharmacy Practice Innovation - A Regulatory and Legal Obstacle Course. The session will discuss the emergence of new and non-traditional pharmacy business models that challenge current regulations and supporting legal foundations. Such models are often funded by venture capitalists and...

In this episode of Post-Scrip, Henry introduces Jennifer L. Adams, PharmD, EdD.  Henry and Jennifer discuss the upcoming Empowering Pharmacists: The Continuum of Prescriptive Authority. Pharmacist prescriptive authority is a topic that has gained significant attention in recent years, as many healthcare professionals recognize the important role that pharmacists can play in improving patient care....

In this episode of Post-Scrip, Henry introduces Jaya F. White and, JD, Edward D. Rickert, JD/Rph. They discuss the upcoming Infusion Pharmacy Services: Regulatory Considerations Impacting the Business Model. This presentation will discuss infusion pharmacy services and the various business models in the industry, including physician, home, and ambulatory infusion suites. It will look at state law...

In this episode of Post-Scrip, Henry introduces  Monet Stanford, PharmD. Henry and Monet dive into The Transition of Biosimilar: From Provider-Administered to Pharmacy-Dispensed.  The biosimilars industry, which started with the first approval in 2015, is at an inflection point. In the U.S., biosimilars could lead to over $130 billion is savings by 2025, and have been used in over 364 million days...

In this episode of Post-Scrip, Henry introduces Larry P. Cote, JD. Larry is the Chief Compliance Officer of Smith Drug Company and CEO of Drug Enforcement Analytics LLC, a veteran-owned business that offers software solutions to assist industry partners with meeting their controlled substance compliance obligations. Henry and Larry dive into the upcoming session on Adapting to the New Normal: Prac...